Literature DB >> 420068

Propranolol withdrawal in angina pectoris: a prospective study.

M G Myers, M R Freeman, Z A Juma, G Wisenberg.   

Abstract

In a prospective study, 100 consecutive patients (mean age 51.3 years) with angina pectoris had propranolol abruptly discontinued 24 to 144 hours (mean 39.0 hours) prior to elective coronary arteriography. The mean duration of therapy was 8.2 months and the mean daily propranolol dose was 216.1 mg. New York Heart Association Class II, III and IV symptoms were present in 30, 41, and 29 patients and one, two, or three coronary arteries were more than 50 per cent narrowed in 37, 29, and 34 cases, respectively. Three patients experienced minor increases in chest pain and two suffered non-transmural myocardial infarctions prior to the time of scheduled cessation of therapy. The same number of minor and major complications occurred in the post-withdrawal period. All four patients who developed non-transmural myocardial infarction in this study had pre-existing Class IV symptoms. The course of the remaining 90 patients was uneventful. These findings do not support the concept of a rebound propranolol withdrawal reaction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420068     DOI: 10.1016/0002-8703(79)90428-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Dr Walker reply.

Authors:  P R Walker
Journal:  Br Heart J       Date:  1986-08

2.  β-blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program.

Authors:  Steve Kwon; Rachel Thompson; Michael Florence; Ronald Maier; Lisa McIntyre; Terry Rogers; Ellen Farrohki; Mark Whiteford; David R Flum
Journal:  Arch Surg       Date:  2012-05

3.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 4.  The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Authors:  B N Prichard; R J Walden
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Adrenergic hypersensitivity after beta-blocker withdrawal.

Authors:  P J Ross; M J Lewis; D J Sheridan; A H Henderson
Journal:  Br Heart J       Date:  1981-06

6.  Beta adrenergic receptor blockade of feline myocardium. Cardiac mechanics, energetics, and beta adrenoceptor regulation.

Authors:  G Cooper; R L Kent; P McGonigle; A M Watanabe
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 7.  Central nervous system mechanisms in blood pressure control.

Authors:  A D Struthers; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects.

Authors:  K S Kiyingi; J Shaw
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Sudden versus gradual withdrawal of sotalol in ambulant patients with ischaemic heart disease.

Authors:  A Henderson; J Errington
Journal:  Br Heart J       Date:  1982-12

10.  Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment.

Authors:  P R Walker; A J Marshall; S Farr; B Bauminger; G Walters; D W Barritt
Journal:  Br Heart J       Date:  1985-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.